35 studies found for:    " November 18, 2009":" December 18, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Suspended Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Conditions: AIDS-related Kaposi Sarcoma;   HIV Infection;   Recurrent Kaposi Sarcoma
Interventions: Drug: bortezomib;   Other: laboratory biomarker analysis
22 Completed Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
Condition: HIV Infections
Intervention:
23 Completed
Has Results
Trichomonas Vaginalis Recurrence Among HIV+ Women
Conditions: Trichomonas Infections;   HIV Infections
Intervention: Drug: Metronidazole
24 Completed Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
25 Completed S.T.A.R.S.: Sistas Talking About Real Solutions
Condition: HIV Prevention
Interventions: Behavioral: STARS: Sistas Talking About Real Solutions;   Behavioral: General Health & Nutrition
26 Completed Exploration of HIV Reservoirs
Condition: HIV-1 Infection
Intervention: Procedure: Rectal mucosa biopsy
27 Recruiting Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Condition: Infections, Papillomavirus
Interventions: Biological: GSK Biologicals' HPV vaccine 580299;   Biological: Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine (Gardasil)
28 Completed ID & Testing in Male Partners
Condition: HIV
Intervention:
29 Completed Contingency Management in the Delivery of HAART to Drug Users in Chennai, India
Conditions: HIV;   Substance Abuse, Intravenous
Interventions: Behavioral: Contingency;   Other: Prize bowl drawings
30 Completed Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression
Condition: HIV
Interventions: Drug: Etravirine 400 mg dissolved in water every 24 hours;   Drug: Continue with the same antiretroviral regimen
31 Active, not recruiting Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART
Condition: HIV-1
Interventions: Biological: MVA.HIVconsv low dose;   Other: Placebo low dose;   Biological: MVA.HIVconsv high dose;   Other: Placebo high dose
32 Completed Self-Managing HIV and Chronic Disease
Condition: HIV/AIDS
Interventions: Behavioral: Individual Telephone Counseling Intervention;   Other: Group Arm;   Other: Book Arm
33 Unknown  Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
Conditions: HIV-1 Infection;   Cancer;   Immunosuppression
Intervention: Other: serologic testing
34 Completed Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients
Condition: HIV-1 Infection
Interventions: Drug: ART Intensification;   Biological: Immunomodulation
35 Completed Observational Study of the Preventive Trial With HIV-1 Tat Protein
Condition: Healthy Subjects
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page
Indicates status has not been verified in more than two years